Aisling Capital Management LP Syndax Pharmaceuticals Inc Transaction History
Aisling Capital Management LP
- $243 Million
- Q3 2024
A detailed history of Aisling Capital Management LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Aisling Capital Management LP holds 1,025,000 shares of SNDX stock, worth $17.1 Million. This represents 8.12% of its overall portfolio holdings.
Number of Shares
1,025,000
Previous 1,025,000
-0.0%
Holding current value
$17.1 Million
Previous $21 Million
6.23%
% of portfolio
8.12%
Previous 9.22%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
228Shares Held
88.4MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$132 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$97.6 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$83.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$81.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$68.6 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $945M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...